CD BioSciences Reveals Its Capabilities in Conducting Proof of Concept Research

CD BioScicences, a US based supplier of professional clinical trial services, is proud to reveal its capabilities in conducting Proof of Concept (PoC) studies. It’s a good news for drug development scientists in life science companies and organizations since they have another option when choosing a qualified CRO partner.

Proof of Concept research is a critically important phase before entering early phase clinical trials and the later phase clinical trials. To simply put, PoC studies are designed to help scientists to gain insights of the practicality of the drug development concept or theory and make strategic decisions about whether and how to move on to the next drug development phase. In this case, the design and implementation of PoC studies become vital to scientists.

CD BioSciences has rich experience in working with domestic and international pharmaceutical as well as biopharmaceutical clients in the early phase of drug development covering clinical pharmacology, first-in-human (FIH) and Proof of Concept. The company features its PoC research service in conducting the most appropriate study design and implementation of PoC trials and pivotal trials with a high-level team of statisticians, medical experts, PV professionals, and regulatory consultants.

“We take custom services seriously.” Says Helen James, Senior Scientist of CD BioSciences, “That’s why we have a team of expert scientists across continents covering major clinical trial facilities. Our clients can sit back and relax when having us to conduct their clinical trials.”

CD BioSciences provides PoC and pivotal clinical research covering almost all therapeutic areas. The company claims to stick with compliant regulatory guidelines when conducting PoC studies. In addition, the company provides a range of biostatistics services in all clinical phases, including but are not limited to study design, PK / PD analysis and modeling, interim analysis, cluster analysis, and etc.

To learn more about CD BioSciences’ clinical trial services as well as the company itself, visit the company's website for more detailed information. The company could also be reached via info@cd-biosciences.net. The staff works at regular business hours from 9:00 am to 6:00 pm, Monday to Friday. Any service inquiry will be answered ASAP once received.

Company Name: CD BioSciences
Press Contact: Michelle Moser
Tel.: 1-315-636-4280
Website: https://www.cd-biosciences.com/
Email: info@cd-biosciences.net
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA

Over a decade’s development, CD BioSciences has grown from a small business to a full cycle clinical trial service supplier in the US. The company’s high-level statisticians and medical experts can serve all phases in clinical development, i.e., bioanalytical lab testing, clinical pharmacology, first-in-human (FIH), PoC and pivotal clinical research, early phase trials, later phase trials, and clinical data management analysis and reporting. Quality is the company’s priority. The company strives for the satisfaction of the customers by reducing their time and cost in drug development.

This release was published on openPR.